Managing drug resistant tuberculosis
نویسندگان
چکیده
منابع مشابه
CLINICAL REVIEW Managing drug resistant tuberculosis
Antituberculosis drug resistance is increasing both in theUnitedKingdomand internationally. 2 It has come to greater public attention with the emergence of extensively drug resistant tuberculosis (box 1) in South Africa, where an outbreak proved rapidly fatal among peoplewith advancedHIV infection. In this articlewe review recent global and UK trends in drug resistant tuberculosis and summarise...
متن کاملExtensively drug-resistant tuberculosis.
Extensively drug-resistant (XDR) tuberculosis is defined as disease caused by Mycobacterium tuberculosis with resistance to at least isoniazid and rifampicin, any fluoroquinolone, and at least one of three injectable second-line drugs (amikacin, capreomycin, or kanamycin). The definition has applicable clinical value and has allowed for more uniform surveillance in varied international settings...
متن کاملDrug Resistant Tuberculosis
Drug resistant tuberculosis (DRTB) has hit the tuberculosis control programs like a thunderbolt. It has challenged all the aspects of tuberculosis management, from diagnosis till prognosis. India has had a major contribution in DR TB worldwide, with Mumbai city being the niche for DRTB strains. DRTB has emerged distinctly as a “Creation of mankind” than solely as a “Weapon of God” to curtail th...
متن کاملDrug-resistant tuberculosis.
The epidemic of drug-resistant tuberculosis (DR-TB) is a public health emergency that threatens to destabilise global TB control. Although TB incidence and mortality are decreasing in several parts of the world, the overall prevalence of multidrug-resistant tuberculosis (MDR-TB) is increasing in many high-burden countries, particularly in Africa.[1] World Health Organization (WHO) statistics sh...
متن کاملmultidrug-resistant and extensively drug-resistant tuberculosis
multidrug-resistant (mdr) and extensively drug-resistant (xdr) tuberculosis (tb) are increasing globally. treatment options for these patients are very limited. although treatment of these patients with standardized regimen is associated with high mortality and morbidity, rational usage of new drugs might be promising. in this study we will review epidemiology of xdr-tb and tdr-tb in iran and t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2008
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.a1110